Biogen: Allergan or Merck? Neither

Whether or not Biogen ( BIIB ) gets bought is the big question among healthcare investors today. The WSJ reported yesterday that Allergan ( AGN ) and Merck ( MRK ) were interested in buying the biotech giant and since then, analysts have weighed in with abandon. But some analysts are at odds over which companies would be the best fit with Biogen, and at least one has already speculated about a price tag.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.